Literature DB >> 18363643

Radial artery calcification in end-stage renal disease patients is associated with deposition of osteopontin and diminished expression of alpha-smooth muscle actin.

Ningning Wang1, Junwei Yang, Xiangbao Yu, Jianming Hu, Changying Xing, Xiaobing Ju, Xia Shen, Jun Qian, Xiufen Zhao, Xiaoyun Wang.   

Abstract

AIM: Vascular access is the lifeline of haemodialysis patients and radial-cephalic fistula is the preferred type of access. We investigated vascular calcification in uraemia radial arteries and compared it with clinical parameters.
METHODS: Artery specimens from 30 end-stage renal disease patients were collected, examined calcification by von Kossa and Alizarin red staining. Expression of alpha-smooth muscle actin (alpha-SMA) and the main component of bone matrix, osteopontin (OP) were detected by immunohistochemistry.
RESULTS: In uraemia vessels, calcification was mainly located in the medial layer. Nineteen (63.33%) patients had no evidence of calcification, six (20%) had mild/moderate calcification and five (16.66%) had severe calcification. Upregulation of OP and diminished expression of alpha-SMA occurred in the medial layer, especially in the area of severe calcification. The calcification score, decreased expression of alpha-SMA and upregulation of OP were positively correlated with older age, serum calcium, serum phosphorus and calcium x phosphorus product (P < 0.01).
CONCLUSION: Vascular calcification in uraemia radial arteries is mainly located in the media layer. The risk factors appear to be older age, an elevated serum level of phosphorus, calcium and calcium x phosphorus product.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363643     DOI: 10.1111/j.1440-1797.2008.00941.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

Review 1.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

2.  Preexisting venous calcification prior to dialysis vascular access surgery.

Authors:  Timmy Lee; Nida Safdar; Meenakshi J Mistry; Yang Wang; Vibha Chauhan; Begoña Campos; Rino Munda; Virgilius Cornea; Prabir Roy-Chaudhury
Journal:  Semin Dial       Date:  2012-03-27       Impact factor: 3.455

3.  Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.

Authors:  Anuja Shah; Clinton J Miller; Cynthia C Nast; Mark D Adams; Barbara Truitt; John A Tayek; Lili Tong; Parag Mehtani; Francisco Monteon; John R Sedor; Erica L Clinkenbeard; Kenneth White; Rajnish Mehrotra; Janine LaPage; Patricia Dickson; Sharon G Adler; Sudha K Iyengar
Journal:  Nephrol Dial Transplant       Date:  2014-11-05       Impact factor: 5.992

4.  p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.

Authors:  K L Li; J Chen; Z H Li; L Zhao; Y N He
Journal:  Cardiovasc J Afr       Date:  2012-07-12       Impact factor: 1.167

5.  Impaired fasting glucose and diabetes as predictors for radial artery calcification in end stage renal disease patients.

Authors:  Katarzyna Janda; Marcin Krzanowski; Mariusz Gajda; Paulina Dumnicka; Danuta Fedak; Grzegorz J Lis; Piotr Jaśkowski; Jan A Litwin; Władysław Sułowicz
Journal:  Int J Endocrinol       Date:  2013-12-18       Impact factor: 3.257

Review 6.  Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients.

Authors:  Ja Young Lee; Young Ok Kim
Journal:  Korean J Intern Med       Date:  2017-08-22       Impact factor: 2.884

7.  Aortic dissection is associated with reduced polycystin-1 expression, an abnormality that leads to increased ERK phosphorylation in vascular smooth muscle cells.

Authors:  J Feng; S Ge; L Zhang; H Che; C Liang
Journal:  Eur J Histochem       Date:  2016-12-16       Impact factor: 3.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.